C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance
- PMID: 16192648
- PMCID: PMC1603667
- DOI: 10.1016/S0002-9440(10)61202-3
C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance
Abstract
C-reactive protein (CRP) is frequently deposited in the lesions of the arterial intima; however, the origin and pathological significance of CRP in these lesions are not completely understood. In this study, we measured CRP levels in the plasma of hypercholesterolemic rabbits and investigated CRP expression at both the mRNA and protein levels using rabbit and human atherosclerotic specimens. CRP levels were significantly elevated in both cholesterol-fed and Watanabe heritable hyperlipidemic rabbits, and CRP levels were clearly correlated with aortic atherosclerotic lesion size. Immunohistochemical staining coupled with Western blotting analysis revealed that CRP-immunoreactive proteins were found at all stages of atherosclerosis from the early to advanced lesions. CRP was present extracellularly and co-localized with apolipoprotein B but was rarely associated with the cytoplasm of macrophages and foam cells. Real-time reverse transcriptase-polymerase chain reaction analysis revealed that CRP mRNA in atherosclerotic lesions was barely detectable, and isolated macrophages did not express CRP mRNA, suggesting that CRP proteins found in the lesions were essentially derived from the circulation rather than synthesized de novo by vascular cells. These results suggest that there is a link between plasma CRP and the degree of atherosclerosis and that inhibition of plasma CRP may represent a therapeutic modality for the treatment of cardiovascular disease.
Figures
Comment in
-
C-reactive protein and atherogenesis: new insights from established animal models.Am J Pathol. 2005 Oct;167(4):923-5. doi: 10.1016/S0002-9440(10)61182-0. Am J Pathol. 2005. PMID: 16192628 Free PMC article. No abstract available.
-
Sources of CRP in atherosclerotic lesions.Am J Pathol. 2006 Mar;168(3):1054-5; author reply 1055-6. doi: 10.2353/ajpath.2006.051175. Am J Pathol. 2006. PMID: 16507918 Free PMC article. No abstract available.
References
-
- Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212. - PubMed
-
- Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279:48487–48490. - PubMed
-
- Taylor AW, Ku NO, Mortensen RF. Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-beta. J Immunol. 1990;145:2507–2513. - PubMed
-
- Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
